T.O. joins me to grill me on the rest of Financial Conflict of Interest and Precision Oncology.  We discuss the need for randomization, and when it can be omitted.  A must listen for Oncology Fans.

5.10 - Adam Cifu on clinical excellence

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com